MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies

Clinical trial NCT02042989 · COMPLETED

Trial details

NCT number: NCT02042989
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers

Start date: 2014-06-27
Primary completion: 2020-01-22
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.